Mayo Clinic
Subject: FW: Comments on IARC
Abstract
Forwards commentary on perceived weaknesses of IARC ETS study, and outlines potential "message points" based on those weaknesses. Highlights need for different approach to reviewing the IARC study from scientific and regulatory perspectives. Emphasizes flawed interpretation of observed relative risks for ETS exposure.
Fields
- Notes
Two Bates numbers are on first page (i.e. no pages are missing)
- Type
- Telex
- Company
- Philip Morris
- Site
- MN Depository
- Author
- Keane, Denise F.
- Recipient
- Ellis, Cathy L.
No images found for document.